SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-069304
Filing Date
2022-06-08
Accepted
2022-06-08 16:07:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2217583-1_s3.htm S-3 386197
2 EXHIBIT 4.3 tm2217583d2_ex4-3.htm EX-4.3 296239
3 EXHIBIT 4.4 tm2217583d2_ex4-4.htm EX-4.4 298896
4 EXHIBIT 5.1 tm2217583d2_ex5-1.htm EX-5.1 15361
5 EXHIBIT 23.1 tm2217583d2_ex23-1.htm EX-23.1 2036
6 EX-FILING FEES tm2217583d2_ex-filingfees.htm EX-FILING FEES 55849
7 GRAPHIC lg_rubiustherapeut-4c.jpg GRAPHIC 68719
8 GRAPHIC tm2217583d2_ex5-1img001.jpg GRAPHIC 3190
  Complete submission text file 0001104659-22-069304.txt   1154916
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265482 | Film No.: 221003593
SIC: 2836 Biological Products, (No Diagnostic Substances)